Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03222518Phase 3Completed
Phase 3, randomised, single-blind trial of piroxicam in acute pain (3 arms), sponsored by Université de Monastir. Primary endpoint: New oral analgesic medications needed rate at 7 days. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03222518.